Health&Science,건강,과학,마케팅,브랜드,브랜드마케팅,기업,서비스마케팅,글로벌,경영,시장,사례

W. Bush`s restrictions on embryonic-stem-cell research.

Some of the federal funds that might otherwise have gone to embryonic stem cells could be finding their way into cancer-stem-cell studies. `Don`t expect anything before five years,` says Weissman, `but be angry if you don`t see anything in 15 years.` Cancer patients, mark your calendars.
The new cancer fighter
DIABETES
Pfizer received approval from the U.S government and an E.U. regulatory panel to market the first inhaled insulin, Exubera. The powdered insulin, taken just before meals, is released into the mouth and lungs through an inhaler similar to the ones that asthma patients use.
In studies, the needle-free insulin was as effective as short-acting insulin shots in controlling blood-sugar levels.
The new cancer fighter
OBESITY
The drug, to be marketed as Acomplia, is being reviewed by the FDA and will be targeted at those who not only carry excess weight but also harbor unhealthy signs of metabolic disorder

(보관된 자료가 없습니다)